Sleep apnea treatment company Apnex Medical developing an implantable device raises $10M
Apnex Medical, which is testing its implantable device to treat obstructive sleep apnea, announced Monday that it has raised $10 million.
FDA approves obstructive sleep apnea clinical trial for Apnex Medical
Only three companies are developing implanted devices to treat obstructive sleep apnea, a condition that affects about 18 million people. On Tuesday, Apnex Medical, one of two sleep apnea treatment startups based in Minnesota, became the second company to get clearance from the U.S. Food and Drug Administration on a clinical trial to test its […]
Polaris Venture Partners raises $233M of $400M fund
Life sciences and IT investment firm Polaris Venture Partners has raised $233 million of an anticipated $400 million fund, according to a filing with the Securities and Exchange Commission. The $400 million goal appears to represent scaled-down expectations for the venture luminary, which had previously targeted $500 million for its sixth fund, VentureWire reported. Polaris’ […]
Apnex Medical names former BSX and J&J executive as its new CEO
Apnex Medical Inc., a St. Paul-based startup developing technology to treat obstructive sleep apnea (OSA), has named Charles McKhann as its new CEO. McKhann, who previously served as a global vice president of marketing for Boston Scientific Corp.’s (NYSE: BSX) cardiac rhythm management division, replaces founder and executive director Robert Atkinson. While at Johnson & […]
Minnesota’s Apnex Medical gains $14M investment for sleep apnea device
The company is developing an implantable neurostimulation device that activates muscles in a patient's upper airway to prevent the tongue from blocking the airway during sleep.